AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 1,224,007 shares, a growth of 252.6% from the December 15th total of 347,179 shares. Based on an average daily volume of 606,982 shares, the days-to-cover ratio is currently 2.0 days. Approximately 5.9% of the company’s shares are short sold. Approximately 5.9% of the company’s shares are short sold. Based on an average daily volume of 606,982 shares, the days-to-cover ratio is currently 2.0 days.
Institutional Investors Weigh In On AGF U.S. Market Neutral Anti-Beta Fund
A number of institutional investors and hedge funds have recently added to or reduced their stakes in BTAL. Creative Financial Designs Inc. ADV boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 2.5% during the third quarter. Creative Financial Designs Inc. ADV now owns 224,292 shares of the company’s stock worth $3,571,000 after buying an additional 5,487 shares during the last quarter. PMV Capital Advisers LLC increased its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 35.5% in the 3rd quarter. PMV Capital Advisers LLC now owns 204,763 shares of the company’s stock valued at $3,260,000 after acquiring an additional 53,603 shares during the last quarter. Magnolia Private Wealth LLC raised its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 266.0% in the 2nd quarter. Magnolia Private Wealth LLC now owns 68,189 shares of the company’s stock valued at $1,207,000 after acquiring an additional 49,560 shares during the period. L.M. Kohn & Company bought a new position in AGF U.S. Market Neutral Anti-Beta Fund during the 2nd quarter worth approximately $570,000. Finally, Worth Asset Management LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund during the fourth quarter valued at approximately $364,000.
AGF U.S. Market Neutral Anti-Beta Fund Trading Up 1.4%
Shares of BTAL traded up $0.20 on Wednesday, reaching $14.01. 362,699 shares of the company’s stock were exchanged, compared to its average volume of 626,622. AGF U.S. Market Neutral Anti-Beta Fund has a 12 month low of $13.66 and a 12 month high of $22.10. The stock has a market capitalization of $290.01 million, a P/E ratio of 17.67 and a beta of -0.66. The business has a 50 day moving average price of $14.67 and a two-hundred day moving average price of $15.64.
AGF U.S. Market Neutral Anti-Beta Fund Announces Dividend
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Read More
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Punch these codes into your ordinary brokerage account
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Zacks Puts $25.50 target on BSEM!
- This AI Opportunity Was Built to Evolve With Demand
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
